tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide)

C222H222F18N30O9 — CID 167634043

IUPACtris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide)
SMILESCC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cc5ccccc5cn4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cc5ccccc5cn4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cc5ccccc5cn4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cccc(C(F)(F)F)c4)c13)C2.CC1CC2(C1)CC(NC(=O)c1ncn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1ncn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2
InChIInChI=1S/3C26H26N4O.6C24H24F3N3O/c3*1-17-11-26(12-17)13-22(14-26)29-25(31)23-16-28-30-8-4-7-19(24(23)30)10-21-9-18-5-2-3-6-20(18)15-27-21;1-15-10-23(11-15)12-19(13-23)29-22(31)20-14-28-30-7-3-5-17(21(20)30)8-16-4-2-6-18(9-16)24(25,26)27;2*1-15-10-23(11-15)12-19(13-23)29-22(31)20-21-17(3-2-8-30(21)14-28-20)9-16-4-6-18(7-5-16)24(25,26)27;3*1-15-10-23(11-15)12-19(13-23)29-22(31)20-14-28-30-8-2-3-17(21(20)30)9-16-4-6-18(7-5-16)24(25,26)27/h3*2-9,15-17,22H,10-14H2,1H3,(H,29,31);2-7,9,14-15,19H,8,10-13H2,1H3,(H,29,31);5*2-8,14-15,19H,9-13H2,1H3,(H,29,31)
InChIKeyOFFCEPOOPOBCOG-UHFFFAOYSA-N
MW3796.38 g/mol
LogP45.86
Rot. Bonds36

About tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide)

tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide) (PubChem CID 167634043) has the molecular formula C222H222F18N30O9 and a molecular weight of 3796.38 g/mol. Its IUPAC name is tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide).

Molecular Properties

Compound Nametris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide)
PubChem CID167634043
Molecular FormulaC222H222F18N30O9
Molecular Weight3796.38 g/mol
Exact Mass3793.75
IUPAC Nametris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide)
SMILESCC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cc5ccccc5cn4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cc5ccccc5cn4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cc5ccccc5cn4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cccc(C(F)(F)F)c4)c13)C2.CC1CC2(C1)CC(NC(=O)c1ncn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1ncn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2
InChIInChI=1S/3C26H26N4O.6C24H24F3N3O/c3*1-17-11-26(12-17)13-22(14-26)29-25(31)23-16-28-30-8-4-7-19(24(23)30)10-21-9-18-5-2-3-6-20(18)15-27-21;1-15-10-23(11-15)12-19(13-23)29-22(31)20-14-28-30-7-3-5-17(21(20)30)8-16-4-2-6-18(9-16)24(25,26)27;2*1-15-10-23(11-15)12-19(13-23)29-22(31)20-21-17(3-2-8-30(21)14-28-20)9-16-4-6-18(7-5-16)24(25,26)27;3*1-15-10-23(11-15)12-19(13-23)29-22(31)20-14-28-30-8-2-3-17(21(20)30)9-16-4-6-18(7-5-16)24(25,26)27/h3*2-9,15-17,22H,10-14H2,1H3,(H,29,31);2-7,9,14-15,19H,8,10-13H2,1H3,(H,29,31);5*2-8,14-15,19H,9-13H2,1H3,(H,29,31)
InChIKeyOFFCEPOOPOBCOG-UHFFFAOYSA-N
XLogP45.86
TPSA456.27 Ų
H-Bond Donors9
H-Bond Acceptors30
Rotatable Bonds36
Heavy Atoms279
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003796.38
LogP ≤ 545.86
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1030

Analyze tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide)?
The IUPAC name of tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide) (CID 167634043) is tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide).
What is the SMILES notation for tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide)?
The canonical SMILES for tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide) is CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cc5ccccc5cn4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cc5ccccc5cn4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cc5ccccc5cn4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1cnn3cccc(Cc4cccc(C(F)(F)F)c4)c13)C2.CC1CC2(C1)CC(NC(=O)c1ncn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.CC1CC2(C1)CC(NC(=O)c1ncn3cccc(Cc4ccc(C(F)(F)F)cc4)c13)C2.
What is the InChIKey of tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide)?
The InChIKey is OFFCEPOOPOBCOG-UHFFFAOYSA-N. The full InChI is InChI=1S/3C26H26N4O.6C24H24F3N3O/c3*1-17-11-26(12-17)13-22(14-26)29-25(31)23-16-28-30-8-4-7-19(24(23)30)10-21-9-18-5-2-3-6-20(18)15-27-21;1-15-10-23(11-15)12-19(13-23)29-22(31)20-14-28-30-7-3-5-17(21(20)30)8-16-4-2-6-18(9-16)24(25,26)27;2*1-15-10-23(11-15)12-19(13-23)29-22(31)20-21-17(3-2-8-30(21)14-28-20)9-16-4-6-18(7-5-16)24(25,26)27;3*1-15-10-23(11-15)12-19(13-23)29-22(31)20-14-28-30-8-2-3-17(21(20)30)9-16-4-6-18(7-5-16)24(25,26)27/h3*2-9,15-17,22H,10-14H2,1H3,(H,29,31);2-7,9,14-15,19H,8,10-13H2,1H3,(H,29,31);5*2-8,14-15,19H,9-13H2,1H3,(H,29,31).
What are the key properties of tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide)?
tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide) has a molecular weight of 3796.38 g/mol, XLogP of 45.86, 36 rotatable bonds, 9 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for tris(4-(isoquinolin-3-ylmethyl)-N-(6-methylspiro[3.3]heptan-2-yl)pyrazolo[1,5-a]pyridine-3-carboxamide);bis(N-(6-methylspiro[3.3]heptan-2-yl)-8-[[4-(trifluoromethyl)phenyl]methyl]imidazo[1,5-a]pyridine-1-carboxamide);N-(6-methylspiro[3.3]heptan-2-yl)-4-[[3-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide;tris(N-(6-methylspiro[3.3]heptan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide) is sourced from PubChem (CID 167634043), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).